Fulgent Genetics (FLGT) Cash from Operations (QoQ) (2016 - 2026)
Fulgent Genetics (FLGT) Cash from Operations (QoQ) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn |
| 10 | Fulgent Genetics | 516.41 Mn | 259.38 Mn | 25.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -434.76% |
| Mar 31, 2026 | 109.08% |
| Dec 31, 2025 | -803.55% |
| Sep 30, 2025 | 136.81% |
| Jun 30, 2025 | -580.91% |
| Mar 31, 2025 | -117.71% |
| Dec 31, 2024 | 261.31% |
| Sep 30, 2024 | -461.94% |
| Jun 30, 2024 | -41.03% |
| Mar 31, 2024 | -51.34% |
| Dec 31, 2023 | 45.83% |
| Sep 30, 2023 | 5.17% |
| Jun 30, 2023 | 223.14% |
| Mar 31, 2023 | -123.81% |
| Dec 31, 2022 | 59.83% |
| Sep 30, 2022 | 86.73% |
| Jun 30, 2022 | -94.09% |
| Mar 31, 2022 | 144.42% |
| Dec 31, 2021 | -49.35% |
| Sep 30, 2021 | 99.97% |